563 related articles for article (PubMed ID: 15655710)
1. New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.
Holz GG
Horm Metab Res; 2004; 36(11-12):787-94. PubMed ID: 15655710
[TBL] [Abstract][Full Text] [Related]
2. A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic beta cells.
Kang G; Chepurny OG; Rindler MJ; Collis L; Chepurny Z; Li WH; Harbeck M; Roe MW; Holz GG
J Physiol; 2005 Jul; 566(Pt 1):173-88. PubMed ID: 15860526
[TBL] [Abstract][Full Text] [Related]
3. Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell.
Holz GG
Diabetes; 2004 Jan; 53(1):5-13. PubMed ID: 14693691
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells.
Tsuboi T; da Silva Xavier G; Holz GG; Jouaville LS; Thomas AP; Rutter GA
Biochem J; 2003 Jan; 369(Pt 2):287-99. PubMed ID: 12410638
[TBL] [Abstract][Full Text] [Related]
5. cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37).
Holz GG; Leech CA; Heller RS; Castonguay M; Habener JF
J Biol Chem; 1999 May; 274(20):14147-56. PubMed ID: 10318832
[TBL] [Abstract][Full Text] [Related]
6. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
Gromada J; Ding WG; Barg S; Renström E; Rorsman P
Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
Gromada J; Brock B; Schmitz O; Rorsman P
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):252-62. PubMed ID: 15569269
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism.
Light PE; Manning Fox JE; Riedel MJ; Wheeler MB
Mol Endocrinol; 2002 Sep; 16(9):2135-44. PubMed ID: 12198249
[TBL] [Abstract][Full Text] [Related]
9. SUR1 regulates PKA-independent cAMP-induced granule priming in mouse pancreatic B-cells.
Eliasson L; Ma X; Renström E; Barg S; Berggren PO; Galvanovskis J; Gromada J; Jing X; Lundquist I; Salehi A; Sewing S; Rorsman P
J Gen Physiol; 2003 Mar; 121(3):181-97. PubMed ID: 12601083
[TBL] [Abstract][Full Text] [Related]
10. Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine.
Doliba NM; Qin W; Vatamaniuk MZ; Li C; Zelent D; Najafi H; Buettger CW; Collins HW; Carr RD; Magnuson MA; Matschinsky FM
Am J Physiol Endocrinol Metab; 2004 May; 286(5):E834-43. PubMed ID: 14736703
[TBL] [Abstract][Full Text] [Related]
11. Ca(2+)-induced Ca(2+) release via inositol 1,4,5-trisphosphate receptors is amplified by protein kinase A and triggers exocytosis in pancreatic beta-cells.
Dyachok O; Gylfe E
J Biol Chem; 2004 Oct; 279(44):45455-61. PubMed ID: 15316011
[TBL] [Abstract][Full Text] [Related]
12. Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility.
Miki T; Minami K; Shinozaki H; Matsumura K; Saraya A; Ikeda H; Yamada Y; Holst JJ; Seino S
Diabetes; 2005 Apr; 54(4):1056-63. PubMed ID: 15793244
[TBL] [Abstract][Full Text] [Related]
13. Acute effect of 3β-hidroxihop-22(29)ene on insulin secretion is mediated by GLP-1, potassium and calcium channels for the glucose homeostasis.
Castro AJ; Cazarolli LH; de Carvalho FK; da Luz G; Altenhofen D; dos Santos AR; Pizzolatti MG; Silva FR
J Steroid Biochem Mol Biol; 2015 Jun; 150():112-22. PubMed ID: 25843210
[TBL] [Abstract][Full Text] [Related]
14. Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.
Gromada J; Holst JJ; Rorsman P
Pflugers Arch; 1998 Apr; 435(5):583-94. PubMed ID: 9479010
[TBL] [Abstract][Full Text] [Related]
15. Glucagon stimulates exocytosis in mouse and rat pancreatic alpha-cells by binding to glucagon receptors.
Ma X; Zhang Y; Gromada J; Sewing S; Berggren PO; Buschard K; Salehi A; Vikman J; Rorsman P; Eliasson L
Mol Endocrinol; 2005 Jan; 19(1):198-212. PubMed ID: 15459251
[TBL] [Abstract][Full Text] [Related]
16. cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets.
Nakazaki M; Crane A; Hu M; Seghers V; Ullrich S; Aguilar-Bryan L; Bryan J
Diabetes; 2002 Dec; 51(12):3440-9. PubMed ID: 12453898
[TBL] [Abstract][Full Text] [Related]
17. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction of PACAP and GLP-1 in pancreatic beta cells.
Leech CA; Holz GG; Habener JF
Ann N Y Acad Sci; 1996 Dec; 805():81-92; discussion 92-3. PubMed ID: 8993395
[TBL] [Abstract][Full Text] [Related]
19. Ligand-induced regulation of glucagon-like peptide-I receptor function and expression in insulin-secreting beta cells.
Fehmann HC; Jiang J; Pitt D; Schweinfurth J; Göke B
Pancreas; 1996 Oct; 13(3):273-82. PubMed ID: 8884849
[TBL] [Abstract][Full Text] [Related]
20. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
